Why the study?
Does intravenous ouabain improve left ventricular performance in patients with a recent acute myocardial infarction?
Does intravenous ouabain improve left ventricular performance in patients with a recent acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Intravenous ouabain improves hemodynamic indexes of left ventricular performance without altering cardiac output in patients with recent acute myocardial infarction.
The effects of intravenous ouabain were assessed in 16 patients with a recent acute myocardial infarction. The mean ± S.E.M. of the values, before and one hour after ouabain, were as follows: left ventricular end-diastolic pressure, 24.8 ± 2.1 and 16.1 ± 2.5 mm Hg; left ventricular stroke work, 65.8 ± 9.5 and 80.9 ± 14.3 g-m per beat; peak first derivative of left ventricular pressure, 1798 ± 150, and 2081 ± 150 mm Hg per second; maximum velocity of contractile element shortening, 1.20 ± 0.04 and 1.41 ± 0.06 muscle lengths per second; and pre-ejection period corrected for heart rate, 135.0 ± 5.0, and 128.8 ± 3.6 msec. These changes were significant (p less than 0.05 for paired determinations). There were no significant changes in cardiac index, heart rate and mean arterial pressure. Although ouabain does not change cardiac output in patients with acute myocardial infarction, it causes significant improvement in other indexes of left ventricular performance.
No takes yet. Share an insight, caveat, or question.
Rahimtoola et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: